Clinical Trials for Igor Puzanov

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCMD1188
06/08/2012
An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
TreatmentVICCPHI0958
02/05/2010
A Phase 1 Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX3397 in Patients with Advanced, Incurable, Solid Tumors in which the Target Kinases Are Linked to Disease Pathophysiology

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.